Biophys J (2009) 96:12639
3.7 Cancer risk by individual GLP-1 RA compound When stratified by individual GLP-1 RAs, liraglutide and semaglutide were associated with reduced risk of gastrointestinal cancers (HR 0.77 and 0.79, respectively), while dulaglutide showed a neutral association (HR 0.91, 95% CI: 0.721.14)
Topical formulations typically face fewer legal hurdles than systemic injectables, making them a safer entry point for non-medical users
Rising Disposable Income: In emerging nations, rising disposable income has resulted in increasing spending on premium personal care and dermatological treatments
Avoid spraying directly onto the lyophilized powder
2007;293(2):F5215 Fung TT, Chiuve SE, McCullough ML, Rexrode KM, Logroscino G, Hu FB